Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 3, 2006BloodOpen Access

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)

View Full Paper
Ask AI
Bookmark
Share

Authors

CTChristian ThiedeUniversity Hospital Carl Gustav CarusSKSina KochUppsala UniversityECEva CreutzigUniversity Hospital Carl Gustav Carus

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Thiede et al. (2006) studied this question.

synapsesocial.com/papers/6a7d0c48da72e8de9c2789dahttps://doi.org/10.1182/blood-2005-08-3167
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An activated receptor tyrosine kinase, TEL/PDGFβR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice2003 · 134 citations
  2. 2AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations2005 · 270 citations
  3. 3Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm2002 · 875 citations
  4. 4Incidence and prognosis of c‐KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias2003 · 324 citations